Pancreatic cancer: Biomarkers for the early detection of PDAC.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. A Composite Index for Distinguishing Benign and Malignant Obstructive Jaundice.International journal of general medicine · 2024
   Article
2. Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer.International journal of molecular sciences · 2022
   Review
3. Carbohydrate-based drugs launched during 2000Acta pharmaceutica Sinica. B · 2022
   Review
4. De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer.Oncogene · 2022
   Article
5. Highly sensitive and portable mRNA detection platform for early cancer detection.Journal of nanobiotechnology · 2021
   Article
6. The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction.Aging · 2020
   Article
7. Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden.F1000Research · 2020
   Article
8. BioMed research international · 2020
   Article
9. CtBP-a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma.Oncogenesis · 2019
   Article
10. SNHG15: a promising cancer-related long noncoding RNA.Cancer management and research · 2019
    Review
11. Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant.Journal of Cancer · 2018
    Article

Corrections and comments

• Comment on
  Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as